chrisvoncsefalvay/vaers-outcomes huggingface dataset:
On 8/3/2021, one day after receiving first vaccine dose, heart palpitations/fluttering and muscle twitches began. I assumed these were a temporary side affect that would go away. After these symptoms persisted accompanied by extreme fatigue, I went to urgent care on 8/9. After normal EKG I was ordered a chest X-ray and sent home to rest and told these symptoms should resolve by themself eventually. Chest X-ray on 8/10 came back normal. Over the course of the next few weeks symptoms did not improve. I visited urgent care again on 9/1/21 with these same symptoms. I had blood drawn to test for antibodies which came back negative. I also had blood drawn to see if muscle twitches were caused by magnesium deficiency but was within normal magnesium levels. I was again told that I should wait for symptoms to resolve. I visited doctor on 9/22/21 and 11/10/21 with similar results.
Eyes began stinging Fri evening 10/16/09. All weekend burning progressed Monday morning 10/18/09 left eye bloody in corner like blood vessel broke. Very sore to touch eyes felt bruised. Continued Tues, Wed. by Thursday redness a bit better but still sore. Now Friday (10/23) redness/soreness continues.
Pain and tenderness at the site of injection in my left shoulder started around midnight on 3/31/16. I woke up later in the AM on the same date to severe pain and tenderness at the site of injection in my left shoulder. I have difficulty moving my arm where the shot was given. It has not improved at all.
Information has been received from a healthcare worker referring to an unspecified patient (age and gender unknown). Information about patient's current condition or medical history was not reported. On 01-APR-2015 the patient was administered with a dose of ZOSTAVAX (dose, route not reported, lot # K014834 with expiration date 14-DEC-2015) which was exposed to a temperature outside of the recommended range. No adverse effect was observed or reported. Additional information has been requested.
This spontaneous report as received from a physician via company representative refers to a 51 year old female patient with codeine allergy. On 20-JAN-2015 the patient was vaccinated with ZOSTAVAX (dose, frequency, route of administration and lot# was unknown). Concomitant medications were unspecified by reporter. On 20-JAN-2015, the patient experienced injection site reaction. The injection site was warm, swelling, itchiness, and there was pain. BENADRYL, unspecified ointment and ZYRTEC was given as treatment for the events. Action taken with ZOSTAVAX was not reported. The patient sought medical attention by making a call to the physician. The outcome of the events was reported as recovering/resolving. The causal relationship between the events and ZOSTAVAX was not reported. No further information was provided. Additional information has been requested.
This non-serious spontaneous case, was initially received on 14-Aug-2017, concerns a 05-year-old male child patient. Physician reports 10 patients who were vaccinated after multiple temperature excursions. This report was 1st of 10 reports. On 08-Mar-2017, the patient was administered with FLUCELVAX QIV (batch number: 186686 (reported as 185586), expiry date: 31-May-2017, dose, route of administration, anatomical location: not reported). On 08-Mar-2017, the patient was vaccinated after multiple temperature excursions. First excursion occurred on 02-Mar-2017 (47-degree F, 14.7h), second on 03-Mar-2017 (47-degree F, 16h) and third on 04-Mar-2017 (47-degree F, 19.75 h) which was characterized by drug administration error. The outcome of the events was not reported.  Non-significant case correction received 14-Aug-2017: Batch number (186686) was captured in the case form and narrative was amended accordingly.
About 12 hours after receiving the shot, I woke up with chills, body aches, and nausea. Fever peaked at 100.4. Could not sleep for 4 hours, probably related to the fever. Took 400mg of motrin after 2 hours of fever, temperature was normal by 10 am.
PATIENT DID NOT/HAS NOT HAD AN ADVERSE RELATED EVENT. Janssen COVID-19 Vaccine EUA - ADMINISTRATION ERROR NOT RELATED TO ADVERSE EVENT. REPORTING PER THE EUA DUE TO ADMINISTRATION OF EXPIRED VACCINE. LOT EXPIRATION DATE 09/21/2021.
herpes zoster; This initial spontaneous report was received from a lawyer regarding a case in litigation and refers to a currently 67 years old female patient. No information was provided regarding medical history, concurrent conditions, or concomitant medications. On or about 28-JAN-2018, the patient was vaccinated with zoster vaccine live (ZOSTAVAX) (lot#, expiration date, dose, dose# and route not specified) for the long-term prevention of shingles and zoster-related conditions. On an unspecified date, the patient experienced herpes zoster. On an unspecified date, the patient was treated by a physician for herpes zoster. The outcome of the event herpes zoster was not reported. The reporter considered the event to be related to zoster vaccine live (ZOSTAVAX).   Additional information has been requested.
This case was reported by a physician via sales rep and described the occurrence of injection site pain in a adolescent female patient who received BEXSERO. On an unknown date, the patient received BEXSERO .5 ml. On an unknown date, less than a day after receiving BEXSERO, the patient experienced injection site pain, lethargy, weakness and influenza-like symptoms. On an unknown date, the outcome of the injection site pain, lethargy, weakness and influenza-like symptoms were recovered/resolved. It was unknown if the reporter considered the injection site pain, lethargy, weakness and influenza-like symptoms to be related to BEXSERO. Additional details were provided as follows: This case was not previously reported to anyone. This case was reported by the physician on behalf of his daughter. The age at vaccination was not reported. The patient had pain right after the injection at the site. The representative mentioned that she was not told of the injection site. The day after the injection, the patient was weak and felt like she had flu like symptoms. The doctor told to the representative that the next day the patient was fine and the doctor did not want to be contacted in any way. The patient had denied permission to contact their physician.
Headache, Fever, numbness of face below the eyes, mouth and jaw. Narrative:
sore arm; flu-like symptoms; fever up to 101.8 degrees; Fatigue; Muscle aches; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever up to 101.8 degrees), FATIGUE (Fatigue) and MYALGIA (Muscle aches) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No medical history reported). Concomitant products included ESCITALOPRAM OXALATE (LEXAPRO) and DILTIAZEM (CARDIZEM [DILTIAZEM]) for an unknown indication.    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever up to 101.8 degrees), FATIGUE (Fatigue) and MYALGIA (Muscle aches). At the time of the report, PAIN IN EXTREMITY (sore arm), INFLUENZA LIKE ILLNESS (flu-like symptoms), PYREXIA (fever up to 101.8 degrees), FATIGUE (Fatigue) and MYALGIA (Muscle aches) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment information provided    This case was linked to MOD-2021-018308 (Patient Link).   Reporter did not allow further contact
Double in size red, hot, swollen. Treated for cellulitis, treated with Keflex.
This is a spontaneous report from a contactable pharmacist through a Pfizer sales representative. A 62-year-old male patient received PREVNAR 13 at 0.5ml single dose for immunization via unspecified route of administration. Medical history included diabetes. On unknown date the patient experienced pneumonia and the patient was hospitalized for it. The outcome of the event was reported as recovered. Sender's Comments: Based on the information provided in the case, a lack of efficacy with PREVNAR 13 in this patient cannot be excluded. Further information like causative agent and serotyping results is needed for a full medical assessment.
Death Narrative: Patient received first COVID vaccine does on 3/13/21 at 07:53 without complications. Home telehealth nurse informed by family member on 3/18/21 the patient passed away on 3/13/21 at approximately 1300. Per medical record documentation, "Patient had been at facility getting COVID vaccine that morning at 0800, came home and was taking out his garbage when he started to stumble and fell to his knee, a neighbor saw and assisted patient up and was walking with him back to the apartment when "...he stopped breathing and feel over, dead." Per medical record review, patient had several co-morbidities including hypertension, hyperlipidemia, chronic hyponatremia, alcohol abuse, alcoholic fatty liver, chronic thrombocytopenia, and GERD.
Subacute progressive emergence of OCD-like behaviors and abnormal, repetitive movements over the month following the first vaccine. Concerns of worsening following second vaccination on 12/15/21. Presented for admission to a local Hospital on 12/28/21 with concerns of progressively worsening behaviors and regressive emotional coping
PT HAD A MOLE LOCATED ON THE ARM THAT WAS RED, MOLE TURNED BROWN AFTER INJECTION NEAR THE AREA
still suffering from symptoms; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (still suffering from symptoms) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (still suffering from symptoms). At the time of the report, VACCINATION COMPLICATION (still suffering from symptoms) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product details was not reported.  Treatment details was not reported .   Reporter did not allow further contact
Pt recvd 2nd dose of measles vax 29NOV90 & approx 6DEC90 pt exp myalgia & lt knee pain; Over the following wk pains in arms became progressively more severe; significantly interfering w/sleep; hand felt stiff; felt very fatigued;
A few hours after the vaccine, patient reported generalized and sharp pain in the left side of her ribs and chest. Patient went to the urgent care and was told my the healthcare team that she has been diagnosed with internal shingles and that it could've been a result of the flu vaccine. Patient wanted to report the possible side effect  of the vaccine. She reported no physical rash, but sharp pain, tingling, and pins and needles.
Reaction at the injection site; Warm to the touch but stated that she does not have fever; Feels sluggish; Sore arm; reaction at the injection site, it was red and stated that half-way down the arm, she has a big red blotch/it is all red and everything; This spontaneous case was reported by a patient and describes the occurrence of VACCINATION SITE REACTION (Reaction at the injection site), FEELING HOT (Warm to the touch but stated that she does not have fever), SLUGGISHNESS (Feels sluggish), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (reaction at the injection site, it was red and stated that half-way down the arm, she has a big red blotch/it is all red and everything) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 012H21B, 047B21A and 045A21A) for COVID-19 vaccination.     Previously administered products included for Drug use for unknown indication: Flu shots (she gets sore arm even with flu shots.). Past adverse reactions to the above products included Pain in arm with Flu shots.   On 17-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In 2021, the patient experienced VACCINATION SITE REACTION (Reaction at the injection site), FEELING HOT (Warm to the touch but stated that she does not have fever), SLUGGISHNESS (Feels sluggish), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (reaction at the injection site, it was red and stated that half-way down the arm, she has a big red blotch/it is all red and everything). The patient was treated with LEVOFLOXACIN (ALEEV) on 12-Dec-2021 for Adverse event, at a dose of 1 dosage form. At the time of the report, VACCINATION SITE REACTION (Reaction at the injection site), FEELING HOT (Warm to the touch but stated that she does not have fever), SLUGGISHNESS (Feels sluggish), PAIN IN EXTREMITY (Sore arm) and VACCINATION SITE ERYTHEMA (reaction at the injection site, it was red and stated that half-way down the arm, she has a big red blotch/it is all red and everything) outcome was unknown.            Concomitant medication information was not provided by the reporter.  Patient stated that she had not yet had covid at all.
This spontaneous report as received from a physician refers to a male patient of unknown age. No information regarding the patient's medical history and concurrent conditions was provided. On unknown dates (reported as "previously"), the patient was vaccinated with 3 doses of ZOSTAVAX, injection, (dose, injection site, route of administration, lot number and expiration date were not reported). There were no concomitant medications reported. On an unknown date, the patient had failed to show titers for zoster. The outcome of the event was unknown at the time of the report. The relatedness between the event and ZOSTAVAX was not provided. Additional information has been requested.
Information has been received from a physician concerning a 20 year old female who in May 2007 was vaccinated with 0.5 ml of the third dose of Gardasil. The patient experienced injection site was red, swollen, and puffed up about a half an inch. The reaction went away about 72 hours after the injection. Medical attention was sought. Additional information has been requested. 10/08/2007 This is in follow-up to report(s) previously submitted on 6/14/2007. Information has been received from a physician concerning her 22 year old daughter with an allergy to chocolate, who on 17-MAY-2007, was vaccinated intramuscularly in the left deltoid with 0.5 ml third dose of GARDASIL (Lot# 657622/0388U). The patient developed a penny size of redness, swelling, and itching that lasted approximately four to five days post vaccination (also reported as 72 hours post vaccination). The patient sought unspecified medical attention. No lab diagnostic studies were taken and there were no illnesses at the time of vaccination. The patient recovered on 21-MAY-2007. Additional information is not expected.
Headache; Migraine; Full body aches; Aching pain in my armpit of my left arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 30 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), intramuscular, administered in arm left, administration date 14Oct2021 07:43 (Lot number: FF8841, Expiration Date: 31Mar2022) at the age of 30 years as dose 3 (booster),single for covid-19 immunisation. The patient had no relevant medical history. Concomitant medication(s) included: FLU VACCINE VII, administration date 21Sep2021. Past drug history included: Flu vaccine for Influenza immunization, reaction(s): "Migraine". Vaccination history included: Bnt162b2 (Dose Number: 2, Batch/Lot No: EL3248, Location of injection: Left upper arm, Route of administration: Intramuscular, Exp: Apr2021), administration date: 04Feb2021, when the patient was 30 years old, for COVID-19 immunization, reaction(s): "Migraine", "GI/Digestion Issues"; Bnt162b2 (Dose Number: 1, Batch/Lot No: EL3248, Location of injection: Left upper arm, Route of administration: Intramuscular, Exp: Apr2021), administration date: 14Jan2021, when the patient was 30 years old, for COVID-19 immunization. The following information was reported: MIGRAINE (non-serious) with onset 15Oct2021 05:30, outcome "recovered" (18Oct2021), described as "Migraine"; PAIN (non-serious) with onset 15Oct2021 05:30, outcome "recovered" (17Oct2021), described as "Full body aches"; HEADACHE (non-serious) with onset 18Oct2021, outcome "recovered" (20Oct2021), described as "Headache"; AXILLARY PAIN (non-serious) with onset 15Oct2021, outcome "recovered" (18Oct2021), described as "Aching pain in my armpit of my left arm". Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of migraine, pain, headache, axillary pain. The patient underwent the following laboratory tests and procedures: blood test: unknown results; hepatobiliary scan: unknown results, notes: HIDA scan performed to asses issue; ultrasound scan: unknown results. Therapeutic measures were not taken as a result of migraine, pain, headache, axillary pain.   Additional information: The patient woke up the morning after booster was received with a migraine and full body aches. The patient treated with excedrine migraine as directed. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Little sore, Friday night (started working Sat/had fever). It blew up to size of the orange. It is going down. Went to MD 2/20/13. Prescribed antibiotic & warm compresses.
Myalgia, Fever, NauseaVomiting, chills, fatigue, injection site pain Narrative: Employee reports symptoms of injection site pain/discomfort, chills, fever (101 F), body aches, weakness, and nausea. Reports took ibuprofen (no dose/frequency provided).
I had sudden rapid heart rate twenty minutes after injection. I let the staff know and they hoked me up to blood pressure monitor and monitored heart rate. My pulse was high at about 103bpm. My blood pressure got as high as 155/84, I believe. I was feeling very uneasy and not like myself. Luckily about twenty minutes later, these symptoms went away. I did not check these two things again, but I felt better. My arm was sore, but I know that was to be expected. I also felt like I could taste a medicine taste for about 24 hours.
The symptons were the ones described in the past form with chronic or long lasting symptons. but the headaches are on and off, same as the passing out feelings i get, one thing that remains mostly constant is difficulty concentrating and the brain fog symptoms and the difficulty focusing.
Fever, muscle sore, body ache, headache, weakness, chills and shaking.
Information has been received from a nurse referring to a male patient of unknown age. Medical history and concomitant medication were not reported. On 10-AUG-2017, the patient was vaccinated with GARDASIL 9 (unspecified dose, lot# and expiration date unknown) intramuscularly to prevent from HPV. A county health center administered the vaccines. While waiting after the GARDASIL 9 was administered, the patient fainted and was "out for less than a minute". No treatment was given for the event and the patient did not seek medical attention. It was reported that the patient was fine now. The causality between the events and the therapy was not reported.
Patient received Influenza Vaccine to Left Deltoid at 1113. Patient in 15 minute waiting area when medic noticed patient's face was red and blotchy with hives, around 1124. Hives were to patient's face, neck and chest. Denied any side effects of difficulty breathing or symptoms of an anaphylactic reaction. Patient instructed to wait 30 minutes, VS monitored and were stable. Hives improved. Patient released at 1145 and instructed to follow up with primary care provider.
7-12-15 immunizations given. 7-13-15 pain and swelling (Mother reports swelling increased tennis ball size). Went to ER. They recommended "ZYRTEC" and vaccine Tdap avoidance. 7/14 swelling reduced per mother swelling measured at approx 50 mm/diameter both directions.
Information has been received from a 26 year old female who in September 2009, was vaccinated with the first dose of GARDASIL. Subsequently, 4 days after the vaccination, the patient experienced malaise, muscle weakness and shortness of breath. The patient recovered from malaise, muscle weakness and shortness of breath after 5 days. The patient consulted to the general physician, and the physician did not find any abnormality in the exam. The patient felt that malaise, muscle weakness and shortness of breath were related to therapy with GARDASIL. The physician considered that the vaccination with GARDASIL was not related with these events. Additional information is not expected.
Neck pain; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NECK PAIN (Neck pain) and HEADACHE (Headache) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced NECK PAIN (Neck pain) and HEADACHE (Headache). At the time of the report, NECK PAIN (Neck pain) and HEADACHE (Headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medication use was not provided by reporter.  Treatment details was not reported by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 22-Apr-2021: NNI
arm soreness; She has 2 boys younger than 18 years old, who received their first dose of the Moderna covid-19 vaccine; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm soreness) and PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (She has 2 boys younger than 18 years old, who received their first dose of the Moderna covid-19 vaccine) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 017B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Apr-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (She has 2 boys younger than 18 years old, who received their first dose of the Moderna covid-19 vaccine). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm soreness). On 13-Apr-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (She has 2 boys younger than 18 years old, who received their first dose of the Moderna covid-19 vaccine) had resolved. At the time of the report, PAIN IN EXTREMITY (arm soreness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medications were provided by the reporter. Reporter reported that the patient exercised to make the arm pain go away. No treatment information was provided
Probable sterile abscess;tx E-mycin; Mom to clinic following phone contact describing sx, lt deltoid inject site indurated, sensitive to touch, warm, pustule @ center of swollen area; Arrangements made for f/u w/MD;